Work

Talactoferrin Alfa, a novel immunomodulatory agent with anti-cancer activity in phase II clinical trials.

Year: 2006

Type: article

Source: Cancer Research

Authors: Atul Varadhachary, Michela Spadaro, Jose Engelmayer, Claudia Curcio, Paul Blezinger, Margalit B. Mokyr, Yenyun Wang, Ve ’ted’ Valli, Guido Forni, Federica Pericle

Institutions: University of Illinois Chicago, University of Turin

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1579541791

FWCI:

Cites:

Cited by:

Related to: 10